Pheton Holdings Ltd
NASDAQ:PTHL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pheton Holdings Ltd
Research & Development
Pheton Holdings Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pheton Holdings Ltd
NASDAQ:PTHL
|
Research & Development
-$93.3k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Y
|
Yidu Tech Inc
HKEX:2158
|
Research & Development
-¥168m
|
CAGR 3-Years
22%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Medlive Technology Co Ltd
HKEX:2192
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Suzhou MedicalSystem Technology Co Ltd
SSE:603990
|
Research & Development
-¥29.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
B-SOFT Co Ltd
SZSE:300451
|
Research & Development
-¥307.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
Research & Development
-¥296.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Pheton Holdings Ltd
Glance View
Pheton Holdings Ltd is a CN-based company operating in Health Care Technology industry. The company is headquartered in Beijing, Beijing and currently employs 11 full-time employees. The company went IPO on 2024-09-05. Pheton Holdings Ltd is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.
See Also
What is Pheton Holdings Ltd's Research & Development?
Research & Development
-93.3k
USD
Based on the financial report for Dec 31, 2024, Pheton Holdings Ltd's Research & Development amounts to -93.3k USD.
What is Pheton Holdings Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-5%
Over the last year, the Research & Development growth was -10%. The average annual Research & Development growth rates for Pheton Holdings Ltd have been -5% over the past three years .
